IMNM Stock Price History and Quote Analysis Insights for Investors
Immunome, Inc.
Stock Price Today
Immunome, Inc. (IMNM) stock surged +5.83%, trading at $14.53 on NASDAQ, up from the previous close of $13.73. The stock opened at $13.90, fluctuating between $13.90 and $15.13 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Company Information
| Employees | 55 |
| Beta | 1.82 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Immunome, Inc. (NASDAQ: IMNM) stock price is $14.53 in the last trading session. During the trading session, IMNM stock reached the peak price of $15.13 while $13.90 was the lowest point it dropped to. The percentage change in IMNM stock occurred in the recent session was 5.83% while the dollar amount for the price change in IMNM stock was $0.80.
The NASDAQ listed IMNM is part of Biotechnology industry that operates in the broader Healthcare sector. Immunome, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Matthew K. Robinson Ph.D.
Chief Technology Officer
Dr. Michael J. Morin Ph.D.
Chief Scientist
Ms. Sandra G. Stoneman Esq.
Chief Legal Officer, Gen. Counsel & Corporation Sec.
Dr. Scott K. Dessain M.D., Ph.D.
Co-founder & Chairman of the Scientific Advisory Board
Mr. Robert Lapetina
Vice President of Fin. & Corporation Controller
Dr. Purnanand Duddu Sarma Ph.D.
Pres, Chief Executive Officer & Director
Ms. Corleen M. Roche
Chief Financial Officer
Dr. Dennis H. Giesing Ph.D.
Chief Devel. Officer
IMNM's closing price is 109.67% higher than its 52-week low of $6.93 where as its distance from 52-week high of $30.96 is -53.06%.
Number of IMNM employees currently stands at 55.
Official Website of IMNM is: https://immunome.com
IMNM could be contacted at phone 610 321 3700 and can also be accessed through its website. IMNM operates from 665 Stockton Drive, Exton, PA 19341, United States.
IMNM stock volume for the day was 783.1K shares. The average number of IMNM shares traded daily for last 3 months was 788.97K.
The market value of IMNM currently stands at $906.92M with its latest stock price at $14.53 and 62.42M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com